The building dated from the middle of the nineteenth century and the entryway, painted white, was a slight nod to the fashion for the Greek Revival style that made its way into the New York town houses of that period.

She shoved the key into the new lock, a Medico, and pushed open the door. Stone moved past her and switched on the light.

What awaited them was a minimally furnished but elegant living room, with a small couch and table. The downstairs "parlor floor" had been "opened up"; a lot of walls had been taken out and a staircase was on one side of the front room. It felt like a modern loft.

Memorabilia from E! was all over, the logo on throw pillows and two empty mugs on the table. The main decoration, however, consisted of publicity photos of Kristen around the walls, a smiling blonde with flowing tresses down over her shoulders. In all of them she was wearing heavy makeup and the photos appeared to have been airbrushed.

They were both trying to absorb what they were actually seeing. Each photo, and there were at least sixteen, was pinned to the walls with a steak knife, all with matching white bone handles.

"Jesus, who do you think did this?" Stone asked. "Could it be that ditzy girl downstairs?"

"I'd say she did it herself. Supposedly the reason she went to the Dorian Institute was because she was having some kind of personal crisis over starting to look older. She was consumed with terminal self‑hate. That's what this has to be about."

"I've never caught her on TV," Stone said, walking over to study one of the photos, "but from what little I saw of her on the street just now, she sure seemed different from these head shots."

"Well, this is exactly how she looked on the tube." She told him the alleged story of how Kristen had ended up at the Dorian Institute. Then she gazed around the room, still having trouble taking it in. "Jesus, this is really sick."

"Ally, I'm absolutely convinced that whatever happened or didn't happen—keep that possibility in mind—to Kristen is connected somehow to the reason Gerex's clinical trials have been put under ironclad security."